Total Payments
$3,668
2024 Payments
$566.92
Companies
33
Transactions
223
Medicare Patients
5,095
Medicare Billing
$300,808
Payment Breakdown by Category
Food & Beverage$3,668 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,668 | 223 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $458.92 | 32 | $0 (2024) |
| Novo Nordisk Inc | $396.69 | 26 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $382.59 | 12 | $0 (2024) |
| GlaxoSmithKline, LLC. | $309.27 | 20 | $0 (2024) |
| PFIZER INC. | $223.78 | 15 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $204.86 | 13 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $181.44 | 13 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $151.24 | 10 | $0 (2024) |
| Zimmer Biomet Holdings, Inc. | $142.04 | 4 | $0 (2020) |
| Lilly USA, LLC | $134.15 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $566.92 | 34 | ABBVIE INC. ($131.93) |
| 2023 | $332.49 | 21 | GlaxoSmithKline, LLC. ($90.40) |
| 2022 | $334.76 | 20 | PFIZER INC. ($79.73) |
| 2021 | $718.34 | 43 | AbbVie Inc. ($197.24) |
| 2020 | $374.54 | 20 | Zimmer Biomet Holdings, Inc. ($116.83) |
| 2019 | $310.18 | 19 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($137.85) |
| 2018 | $376.33 | 27 | Novo Nordisk Inc ($75.26) |
| 2017 | $654.12 | 39 | Boehringer Ingelheim Pharmaceuticals, Inc. ($131.91) |
All Payment Transactions
223 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/11/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $35.22 | General |
| Category: NEUROLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.68 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.05 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: RESPIRATORY | ||||||
| 09/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.84 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: RESPIRATORY | ||||||
| 08/27/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: Diabetes | ||||||
| 08/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: NEUROSCIENCE | ||||||
| 08/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: Diabetes | ||||||
| 07/18/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 07/16/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Diabetes Care | ||||||
| 07/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $19.23 | General |
| 06/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Diabetes | ||||||
| 06/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: NEUROSCIENCE | ||||||
| 05/08/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Diabetes Care | ||||||
| 05/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/29/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: IMMUNOLOGY | ||||||
| 04/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $21.01 | General |
| 04/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 927 | 2,307 | $143,505 | $62,762 |
| 2022 | 15 | 972 | 2,304 | $139,565 | $63,178 |
| 2021 | 18 | 1,387 | 3,151 | $192,930 | $87,508 |
| 2020 | 22 | 1,809 | 3,943 | $234,080 | $87,360 |
Total Patients
5,095
Total Services
11,705
Medicare Billing
$300,808
Procedure Codes
70
All Medicare Procedures & Services
70 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 150 | 293 | $45,465 | $26,675 | 58.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 98 | 107 | $21,400 | $13,338 | 62.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 126 | 201 | $21,450 | $12,528 | 58.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 111 | 372 | $18,580 | $3,697 | 19.9% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 101 | 302 | $7,655 | $1,548 | 20.2% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 25 | 28 | $2,100 | $1,516 | 72.2% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 15 | 34 | $1,700 | $881.40 | 51.8% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 19 | 23 | $1,725 | $861.81 | 50.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 40 | 54 | $2,160 | $514.08 | 23.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 84 | 117 | $2,340 | $398.97 | 17.1% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 14 | 15 | $600.00 | $243.00 | 40.5% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 81 | 544 | $13,600 | $219.90 | 1.6% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 12 | 12 | $300.00 | $148.20 | 49.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 11 | 11 | $550.00 | $113.30 | 20.6% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 40 | 194 | $3,880 | $79.89 | 2.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 161 | 316 | $47,400 | $29,034 | 61.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 104 | 112 | $22,400 | $13,856 | 61.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 116 | 168 | $16,800 | $10,861 | 64.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 109 | 357 | $17,850 | $3,624 | 20.3% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2022 | 97 | 302 | $7,550 | $1,602 | 21.2% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 24 | 28 | $1,680 | $1,173 | 69.9% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 48 | 66 | $2,640 | $637.19 | 24.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 13 | 13 | $975.00 | $496.86 | 51.0% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 15 | 15 | $1,125 | $461.00 | 41.0% |
| 81002 | Urinalysis, manual test | Office | 2022 | 80 | 108 | $2,160 | $373.90 | 17.3% |
About Dr. James Polk, M.D
Dr. James Polk, M.D is a Family Medicine healthcare provider based in Richland, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2005. The National Provider Identifier (NPI) number assigned to this provider is 1083601348.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Polk, M.D has received a total of $3,668 in payments from pharmaceutical and medical device companies, with $566.92 received in 2024. These payments were reported across 223 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($3,668).
As a Medicare-enrolled provider, Polk has provided services to 5,095 Medicare beneficiaries, totaling 11,705 services with total Medicare billing of $300,808. Data is available for 4 years (2020–2023), covering 70 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Richland, MS
- Active Since 10/03/2005
- Last Updated 04/19/2011
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1083601348
Products in Payments
- VRAYLAR (Drug) $331.85
- TRELEGY ELLIPTA (Drug) $309.27
- JARDIANCE (Drug) $279.01
- XIFAXAN (Drug) $204.86
- ELIQUIS (Drug) $198.18
- Ozempic (Drug) $155.47
- JANUVIA (Drug) $141.34
- FARXIGA (Drug) $113.30
- Tresiba (Drug) $101.39
- Bellatek (Device) $82.73
- UBRELVY (Drug) $78.74
- SYNTHROID (Drug) $77.51
- ENTRESTO (Drug) $71.06
- TRINTELLIX (Drug) $69.17
- LATUDA (Drug) $66.73
- Victoza (Drug) $65.87
- TRADJENTA (Drug) $63.02
- Tapered Screw (Device) $59.31
- LINZESS (Drug) $56.43
- TOUJEO (Drug) $53.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Richland
Douglas Crawford, D.o, D.O
Family Medicine — Payments: $17,572
Family Medicine $17,572
Martin Coker, M.d, M.D
Family Medicine — Payments: $10,688
Family Medicine $10,688
Dr. Douglas Hargrave, D.o, D.O
Family Medicine — Payments: $8,275
Family Medicine $8,275
Mr. Matthew Lawrence, Md, MD
Family Medicine — Payments: $8,057
Family Medicine $8,057
Dr. Scott Kelly, M.d, M.D
Family Medicine — Payments: $4,838
Family Medicine $4,838
David Merkley, Md, MD
Family Medicine — Payments: $3,884
Family Medicine $3,884